Particularly, the missense variant of CHEK2 I157T was significantly associated with ovarian cystadenomas, borderline ovarian tumors, and low-grade invasive cancers but not high-grade ovarian cancer [78]. This evidence concerns the gene CHEK2 and ovarian cancer.